rs622082

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002180.3(IGHMBP2):​c.2011A>G​(p.Thr671Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.295 in 1,613,488 control chromosomes in the GnomAD database, including 74,641 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T671R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.25 ( 5443 hom., cov: 33)
Exomes 𝑓: 0.30 ( 69198 hom. )

Consequence

IGHMBP2
NM_002180.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -1.58

Publications

64 publications found
Variant links:
Genes affected
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]
IGHMBP2 Gene-Disease associations (from GenCC):
  • autosomal recessive distal spinal muscular atrophy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease axonal type 2S
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary peripheral neuropathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.5120378E-4).
BP6
Variant 11-68936491-A-G is Benign according to our data. Variant chr11-68936491-A-G is described in ClinVar as Benign. ClinVar VariationId is 258566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGHMBP2NM_002180.3 linkc.2011A>G p.Thr671Ala missense_variant Exon 13 of 15 ENST00000255078.8 NP_002171.2 P38935

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGHMBP2ENST00000255078.8 linkc.2011A>G p.Thr671Ala missense_variant Exon 13 of 15 1 NM_002180.3 ENSP00000255078.4 P38935

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
37938
AN:
151982
Hom.:
5448
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.152
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.377
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.455
Gnomad FIN
AF:
0.365
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.305
Gnomad OTH
AF:
0.239
GnomAD2 exomes
AF:
0.291
AC:
72856
AN:
250432
AF XY:
0.307
show subpopulations
Gnomad AFR exome
AF:
0.123
Gnomad AMR exome
AF:
0.129
Gnomad ASJ exome
AF:
0.368
Gnomad EAS exome
AF:
0.196
Gnomad FIN exome
AF:
0.379
Gnomad NFE exome
AF:
0.311
Gnomad OTH exome
AF:
0.296
GnomAD4 exome
AF:
0.300
AC:
438739
AN:
1461388
Hom.:
69198
Cov.:
54
AF XY:
0.308
AC XY:
223655
AN XY:
727002
show subpopulations
African (AFR)
AF:
0.120
AC:
4031
AN:
33480
American (AMR)
AF:
0.132
AC:
5910
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
9501
AN:
26134
East Asian (EAS)
AF:
0.215
AC:
8525
AN:
39700
South Asian (SAS)
AF:
0.456
AC:
39348
AN:
86254
European-Finnish (FIN)
AF:
0.377
AC:
19975
AN:
53038
Middle Eastern (MID)
AF:
0.351
AC:
2024
AN:
5768
European-Non Finnish (NFE)
AF:
0.298
AC:
331637
AN:
1111916
Other (OTH)
AF:
0.295
AC:
17788
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
19689
39379
59068
78758
98447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10700
21400
32100
42800
53500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.249
AC:
37933
AN:
152100
Hom.:
5443
Cov.:
33
AF XY:
0.254
AC XY:
18920
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.128
AC:
5335
AN:
41528
American (AMR)
AF:
0.180
AC:
2757
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.377
AC:
1309
AN:
3470
East Asian (EAS)
AF:
0.198
AC:
1018
AN:
5154
South Asian (SAS)
AF:
0.455
AC:
2192
AN:
4814
European-Finnish (FIN)
AF:
0.365
AC:
3866
AN:
10580
Middle Eastern (MID)
AF:
0.364
AC:
107
AN:
294
European-Non Finnish (NFE)
AF:
0.305
AC:
20710
AN:
67958
Other (OTH)
AF:
0.237
AC:
500
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1428
2857
4285
5714
7142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.287
Hom.:
21512
Bravo
AF:
0.225
TwinsUK
AF:
0.293
AC:
1086
ALSPAC
AF:
0.300
AC:
1155
ESP6500AA
AF:
0.127
AC:
559
ESP6500EA
AF:
0.308
AC:
2645
ExAC
AF:
0.298
AC:
36138
Asia WGS
AF:
0.302
AC:
1047
AN:
3478
EpiCase
AF:
0.303
EpiControl
AF:
0.310

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 03, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Nov 23, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29083408, 32640185) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive distal spinal muscular atrophy 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive distal spinal muscular atrophy 1;C4015349:Charcot-Marie-Tooth disease axonal type 2S Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease axonal type 2S Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.0060
DANN
Benign
0.24
DEOGEN2
Benign
0.080
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.13
T
MetaRNN
Benign
0.00025
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.49
N
PhyloP100
-1.6
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.27
N
REVEL
Benign
0.18
Sift
Benign
0.94
T
Sift4G
Benign
0.73
T
Polyphen
0.0
B
Vest4
0.0090
MPC
0.19
ClinPred
0.00067
T
GERP RS
-6.7
PromoterAI
-0.024
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.024
gMVP
0.25
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs622082; hg19: chr11-68703959; COSMIC: COSV54820189; COSMIC: COSV54820189; API